Baudax Bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 7.38 million compared to USD 7.53 million a year ago. Basic loss per share from continuing operations was USD 1.49 compared to USD 24.2 a year ago. Basic loss per share was USD 1.51 compared to USD 41.95 a year ago.
For the six months, net income was USD 4.03 million compared to net loss of USD 20.34 million a year ago. Basic loss per share from continuing operations was USD 4.08 compared to USD 89.4 a year ago. Basic earnings per share was USD 1.12 compared to basic loss per share of USD 145.03 a year ago.